Free tool
FAERS Monitor: Fluoxetine Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 202133 or its brand name (Fluoxetine Hydrochloride, Fluoxetine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
13,085
Serious
9,897
76% of reports
Hospitalization
4,269
Death reported
1,521
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- headache934
- drug ineffective876
- off label use849
- fatigue793
- drug interaction789
- nausea749
- toxicity to various agents730
- intentional overdose684
- dizziness657
- dyspnoea645
- diarrhoea620
- suicide attempt581
- fall564
- vomiting548
- somnolence479
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 148 |
| 2005 | 118 |
| 2006 | 100 |
| 2007 | 124 |
| 2008 | 163 |
| 2009 | 107 |
| 2010 | 107 |
| 2011 | 231 |
| 2012 | 224 |
| 2013 | 212 |
| 2014 | 266 |
| 2015 | 383 |
| 2016 | 293 |
| 2017 | 495 |
| 2018 | 584 |
| 2019 | 637 |
| 2020 | 515 |
| 2021 | 714 |
| 2022 | 1,352 |
| 2023 | 1,496 |
| 2024 | 1,738 |
| 2025 | 1,678 |
| 2026 | 1,400 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,074 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| intentional overdoseSignal | 684 | 17.3 | 16.1 | 10,419 |
| suicide attemptSignal | 581 | 15.5 | 14.3 | 7,837 |
| drug interactionSignal | 789 | 8.0 | 7.5 | 4,861 |
| toxicity to various agentsSignal | 730 | 7.0 | 6.5 | 3,751 |
| somnolenceSignal | 479 | 3.8 | 3.5 | 1,006 |
| fallSignal | 564 | 2.7 | 2.5 | 624 |
| headacheSignal | 934 | 2.4 | 2.3 | 781 |
| dizzinessSignal | 657 | 2.1 | 2.0 | 396 |
| vomiting | 548 | 1.9 | 1.7 | 228 |
| dyspnoea | 645 | 1.8 | 1.7 | 250 |
| fatigue | 793 | 1.6 | 1.5 | 204 |
| off label use | 849 | 1.6 | 1.5 | 177 |
| diarrhoea | 620 | 1.5 | 1.4 | 122 |
| nausea | 749 | 1.5 | 1.4 | 139 |
| drug ineffective | 876 | 1.1 | 1.0 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.